期刊文献+

miR-21介导的结肠癌细胞对5-氟尿嘧啶的耐药机制研究 被引量:9

Drug resistance of colon cancer cells to 5-fluorouracil mediated by microRNA-21
原文传递
导出
摘要 目的通过检测microRNA-21(miR-21)及其靶基因程序性细胞死亡因子4(programmedcelldeath4,PDCj)4)基因在结肠癌细胞中对下游通路的调控,研究高表达的miR-21在结肠癌细胞中对5-氟尿嘧啶(5-fuorouracil,5-FU)耐药的可能机制。方法MTT法检测5-FU处理后miR-21敲除或PDCD4高表达对RKO细胞存活率的影响;流式细胞术检测5-FU处理后RKO-敲除型与RKO-野生型细胞凋亡;定量PCR检测miR-21敲除后以及PDCD4高表达后RKO细胞中ABCC5及CD44mRNA水平的变化。结果5-FU对RKO-野生型的半抑制浓度(IC50)值(52.28±0.05)μmol/L比RKO-敲除型的ICso值(32.13±0.05)μmol/L高67%,同时miR-21敲除后细胞凋亡率显著增加;PDCD4在RKO-敲除型细胞中显著高表达,并且高表达的PDCD4能够负调控转运蛋白ABCC5及干细胞表面标记CD44。结论miR-21很可能通过抑制靶基因PDCD4调控转运蛋白ABCC5及干细胞表面标记CD44的表达,从而增强RKO细胞对5-FU的耐药性。 Objective To explore downstream regulatory pathway of microRNA-21 (miR-21) in colon cancer cells (RKO) through detecting miR-21 and its target PDCD4, and the influence of miR-21 regulation on the sensitivity of RKO cells to 5-fluorouracil (5-FU). Methods 3-[-4, 5-dimethylthiazol-2-yl]-2, 5- diphenyltetrazolium bromide (MTT) assay was used to determine the effect of 5-FU on the viability of RKO cells with knockout of miR-21 or high expression of PDCD4. Real-time was used to determine the expression of PDCD4, ABCC5 and CD44 in RKO cell after knockout of miR-21. Results MTT assay reveals that the ICs0 of 5-FU in RKO-WT cells [(52.82±0.06) μmol/L] was^67% higher than in miR-21 knockout cells F(32. 23±0. 05) μmol/L] (P〈0.05), and the apoptosis ratio elevated after knockout of miR-21. High expression of PDCD4, a target gene of miR-21, can negatively regulate the expression of ABC transporter ABCC5 and the stem cell marker CD44. Conclusion MiR-21 can mediate the drug resistance to 5-FU by inhibiting its target PDCD4, which can regulate the expression of ABCC5 and CD44 genes.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2015年第5期620-624,共5页 Chinese Journal of Medical Genetics
基金 中央高校基本科研业务费专项资金(SWJTU11CX116) 四川省青年科技创新研究团队资助(2011JTD0026)
关键词 MICRORNA-21 结肠癌细胞 5-氟尿嘧啶 程序性细胞死亡因子4基因 MicroRNA-21 Colon cancer cells 5-fluorouracil PDCD4 gene
  • 相关文献

参考文献17

  • 1邓艳红,兰平.综合治疗对中低位直肠癌功能保护的意义[J].中华胃肠外科杂志,2007,10(4):396-398. 被引量:4
  • 2Chau I, Cunningham D. Chemotherapy in colorectal cancer: new options and new challenges[J]. Br Med Bullet, 2002, 64: 159- 180.
  • 3Pratt S, Shepard RL, Kandasamy RA, et al. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites [J]. Mol Cancer Ther, 2005, 4(5): 855-863.
  • 4Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci U S A, 2006, 103(7) ..2257-2261.
  • 5Bandr6s E, Cubedo E, Agirre X, et al. Identification by real- time PCR of 13 mature microRNAs differentially expressed in coloreetal cancer and non-tumoral tissue[J]. Mol Cancer, 2006, 5:29.
  • 6Li S, Liang Z, Xu L, et al. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases [J]. Mol Cell Biochem, 2012, 360(1-2) =147-158.
  • 7Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4) :425-436.
  • 8Wang P, Zou F, Zhang X, et al. microRNA-21 negativelyregulates Cdc25A and cell cycle progression in colon cancer cells [J]. Cancer Res, 2009, 69(20):8157-8165.
  • 9Pan X, Wang ZX, Wang R. MicroRNA-21: A novel therapeutic target in human cancer[J]. Cancer Biol Ther, 2010, 10(12): 1224-1232.
  • 10Medina PP, Nolde M, Slack FJ, et al. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-eell lymphoma[J]. Nature, 2010, 467(7311) :86-90.

二级参考文献28

  • 1邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
  • 2肖毅,吴斌,林国乐,邱辉忠.中低位直肠癌的新辅助治疗[J].肿瘤学杂志,2006,12(3):169-171. 被引量:4
  • 3Plaschke J, Kruger S, Dietmaier W, et al. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumortissue. Hum Mutant,2004,23: 285.
  • 4Wijnen J, van der Klift H, Vasen H, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet, 1998,20 :326-328.
  • 5Wang Y, Friedl W, Sengteller M, et al. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Hum Mutant, 2002,19 : 279-286.
  • 6Wang Y, Friedl W, Lamberti C,et al. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 andMLH1 genes, lnt J Cancer, 2003, 103 : 636-641.
  • 7Peltomaki P. Deficient DNA mlsmatch repair: a common etiologic factor foreoloneaneer. Hum Mol Genet,2001,10 : 735-740.
  • 8Charbonnier F, Raux G, Wang Q. et al. Detection of exon deletions and duplieations of the mismatch repair genes in hereditary nonpolyposis eoloreetal eancer families using multiplex polymerase ehain reaetion of short fluorescent fragments. Caucer Res,2000,60 : 2760-2763.
  • 9Charbonnier F, Olschwang S, Wang Q, et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.Cancer Res,2002,62 ; 848-853.
  • 10Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol, 2001:533-543.

共引文献7

同被引文献50

  • 1陈黎,王争,陈锦先.术中使用缓释型5-FU对于进展期结肠癌的疗效研究[J].外科理论与实践,2007,12(5):499-501. 被引量:13
  • 2Zhang Z, Wang J, He J, et al. Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population [ J ]. PLoS One, 2013, 8 (10) :e77723. DOI: 10. 1371/journal. pone. 0077723.
  • 3Triano LR, Deshpande H, Gettinger SN. Management of patients With advanced non-small cell lung cancer: current and emerging options[ J]. Drugs, 2010, 70 ( 2 ) : 167-179. DOI: 10. 2165/ 11532200 -000000000-00000.
  • 4Lee DL, Wright KA, Shivers RR. A freeze-fracture study of the cuticle of adult Nippostrongylus brasiliensis (Nematoda) [ J ]Parasitology, 1993, 107 ( Pt 5) :545-552.
  • 5Calin GA, Croce CM. MicroRNA signatures in human cancers [ J]. Nat Rev Cancer, 2006, 6 ( 11 ) : 857-866. DOI : 10. 1038/ nrc1997.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer[ J]. Nat Rev Cancer, 2006, 6 (4) : 259-269. DOI : 10. 1038/nre 1840.
  • 7Xu LF, Wu ZP, Chen Y, et al. MicroRNA-21 ( miR-21 ) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China [ J ]. PLoS One, 2014, 9 ( 8 ) : e103698. DOT:10. 1371/journal. pone. 0103698.
  • 8Li T, Leong MH, Harms B, et al. MicroRNA-21 as a potential colon and rectal cancer biomarker [ J ]. World J Gastroenterol, 2013, 19(34) :5615-5621. DOI:I0. 3748/wjg. v19. i34. 5615.
  • 9Kadera BE, Li L, Toste PA, et al. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis[J]. PLoS One, 2013, 8(8):e71978. DOI:I0. 1371/ journal, pone. 0071978.
  • 10Ono M, Yamada K, Avolio F, et al. Targeted Knock-Down of miR21 Primary Transcripts Using snoMEN Vectors Induces Apoptosis in Human Cancer Cell Lines[ J]. PLoS One, 2015, 10 (9) : e0138668. DOI : 10. 1371/journal. pone. 0138668.

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部